PeerVoice Clinical Pharmacology Audio

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

Eine durchschnittliche Folge dieses Podcasts dauert 19m. Bisher sind 490 Folge(n) erschienen. .

Gesamtlänge aller Episoden: 8 days 18 minutes

subscribe
share






Expert Guidance for Improving Outcomes in Advanced NSCLC: Utilising ADCs in Practice


Expert Guidance for Improving Outcomes in Advanced NSCLC: Utilising ADCs in Practice


share








   24m
 
 

Ask, Spot, Refer: Identifying Acute Hepatic Porphyria in the Emergency Room


Ask, Spot, Refer: Identifying Acute Hepatic Porphyria in the Emergency Room


share








   28m
 
 

Right Drug, Right Patient, Right Time: Cases in “Precisionalised” Treatment of Advanced NSCLC


Right Drug, Right Patient, Right Time: Cases in “Precisionalised” Treatment of Advanced NSCLC


share








   27m
 
 

Managing Cytopenic Myelofibrosis: New and Emerging Therapies and Who May Benefit


Managing Cytopenic Myelofibrosis: New and Emerging Therapies and Who May Benefit


share








   18m
 
 

Metabolic Health of PLWH: What Needs to Be Considered When Initiating or Switching ART?


Metabolic Health of PLWH: What Needs to Be Considered When Initiating or Switching ART?


share








   26m
 
 

Personalised Management of Newly Diagnosed Secondary Acute Myeloid Leukaemia: Determining Factors That Impact Treatment Decisions


Personalised Management of Newly Diagnosed Secondary Acute Myeloid Leukaemia: Determining Factors That Impact Treatment Decisions


share








   20m
 
 

Reassessing Management of Advanced and Recurrent Endometrial Cancer: The Value of Multidisciplinary and Overall Care


Reassessing Management of Advanced and Recurrent Endometrial Cancer: The Value of Multidisciplinary and Overall Care


share








 2022-08-31  55m
 
 

Question Time: Applying New Therapies for the Management of mTNBC


Question Time: Applying New Therapies for the Management of mTNBC


share








 2022-08-25  38m
 
 

New Biomarkers, New Targets in Advanced NSCLC


New Biomarkers, New Targets in Advanced NSCLC


share








 2022-08-17  20m
 
 

Managing Generalised Myasthenia Gravis: A Tale of Two Targets


Managing Generalised Myasthenia Gravis: A Tale of Two Targets


share








 2022-08-10  1h0m